Displaying drugs 15951 - 15975 of 16100 in total
CRA_10656
Experimental
Fenoxazoline
Experimental
7-Deazaguanine
Experimental
Immucillin-G
Experimental
CRx-401
CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. In third-party clinical studies, the dose of bezafibrate contained in CRx-401 has been...
Investigational
Matched Description: … lipid profiles, and this dose has proven to be well tolerated in clinical trials. ... in CRx-401 has been observed to have a positive impact on cellular pathways that influence glycemic and …
CRA-9334
Experimental
Phenylacetaldehyde
Experimental
Benzylamine
Experimental
Para-Bromobenzyl Alcohol
Experimental
4-Fluorobenzylamine
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
N-phenylthiourea
Experimental
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol
Experimental
Bisphenol Z
Experimental
2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL
Experimental
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE
Experimental
Dapaconazole
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Ritanserin
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
Viminol
Experimental
Displaying drugs 15951 - 15975 of 16100 in total